UAE Pacemaker Market to grow with a CAGR of 3.52%

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Pacemaker Market.

According to TechSci Research report, “UAE Pacemaker Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Pacemaker Market has valued at USD 48.07 million in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 3.52% through 2028. This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market.

The rise in disposable income is a significant driver for the demand in the UAE Pacemaker Market. With higher disposable income, individuals are more likely to afford expensive medical treatments, including pacemaker implantation. This increased affordability can lead to a higher demand for pacemakers as more people can access and afford these advanced medical devices. Individuals with higher disposable incomes may have a greater preference for advanced and specialized healthcare services. Pacemakers are sophisticated medical devices that fall into this category, and the demand for such services is likely to increase with higher disposable income. Individuals with higher incomes often have comprehensive health insurance coverage. This, coupled with increased disposable income, makes elective medical procedures, such as pacemaker implantation, more feasible. Insurance coverage can play a crucial role in making these procedures accessible to a broader.

Patients with higher disposable incomes may prefer the latest and most advanced pacemaker technologies. This can drive the demand for newer models and features, stimulating innovation in the market. Pacemakers and their implantation procedures can be expensive. Increased disposable income reduces financial barriers for patients, making them more willing to invest in their health and well-being. Individuals with higher disposable incomes may prioritize maintaining a high quality of life. Pacemakers can significantly improve the quality of life for individuals with heart rhythm disorders, making them more willing to invest in such medical interventions.

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Pacemaker Market.”

In February 2023, Sheikh Shakhbout Medical City (SSMC), one of the largest hospitals in the UAE specializing in serious and complex care, achieved a milestone by successfully conducting a leadless cardiac pacemaker procedure for the treatment of a Emirati patient. This significant case utilized cutting-edge technology recently sanctioned by the US Food and Drug Administration (FDA) in 2022. The advanced pacing system addresses the patient's bradycardia, a condition characterized by a slow heart rhythm, by generating electrical pulses that stimulate the heart to beat at a normal rate. The FDA-approved device was implanted through a minimally invasive procedure, avoiding the need for a surgical incision. Instead, it was introduced through a tube inserted into a blood vessel in the groin and connected to the heart.

Demographic changes present challenges in the UAE Pacemaker Market. As the population ages, there is a higher likelihood of individuals developing cardiovascular issues that may require pacemakers. An aging demographic often means a higher prevalence of conditions such as bradycardia, atrial fibrillation, and heart block. Demographic changes can lead to shifts in disease patterns. In the context of pacemakers, an aging population may experience an increased incidence of heart rhythm disorders, contributing to a higher demand for pacemakers. The aging demographic places additional demands on healthcare resources, including cardiac care services. Allocating resources to meet the needs of an aging population, including access to pacemaker treatments, becomes a challenge. Demographic changes may be associated with an increase in the prevalence of comorbidities, such as diabetes and hypertension. These conditions can contribute to cardiovascular issues, further driving the demand for pacemakers.

UAE Pacemaker Market is segmented based on Material Type, Technology, Product Type, Application, End User, and by region.  

Based on the Application, UAE Pacemaker Market is segmented into Arrythmias, Congestive Heart Failure, Others. Arrhythmias are irregular heart rhythms or abnormal heartbeats that can occur when the electrical impulses controlling the heartbeat are disrupted. The heart's electrical system is responsible for coordinating the contraction of the heart muscle chambers (atria and ventricles), and any disturbance in this system can lead to arrhythmias. Arrhythmias can range from harmless to life-threatening, and they may occur in the atria (upper chambers) or ventricles (lower chambers) of the heart. Tachycardia refers to a faster-than-normal heartbeat. It can originate in the atria (supraventricular tachycardia) or the ventricles (ventricular tachycardia). Tachycardias can cause palpitations, dizziness, and, in severe cases, lead to fainting or cardiac arrest.

Based on Region, Abu Dhabi region held the largest share in the UAE Pacemaker Market. Government initiatives and policies, particularly in the capital city, may prioritize the advancement of healthcare services. This could include investments in medical infrastructure, training programs, and the adoption of the latest medical technologies. The population density and demographics of Abu Dhabi may contribute to a higher prevalence of cardiovascular diseases, necessitating a greater demand for pacemakers. Abu Dhabi is a medical tourism hub, individuals from within the UAE and abroad may travel to the city for specialized medical procedures, including pacemaker implantation, further boosting the demand in the region.

Some of the major companies operating in the UAE Pacemaker Market include:

• Medtronic Meta FZ-LLC
• Boston Scientific Corporation UAE
• Abbott Laboratories, S.A.
• GE Healthcare UAE
• BIOTRONIK, UAE

Download free Sample Report

Customers can also request 10% free customization on this report.

“Certain areas, particularly in Dubai, are projected to exert significant demand for Pacemaker. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the UAE Pacemaker Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

UAE Pacemaker Market by Type (Implantable, External), By Technology (Single Chamber, Dual Chamber, Biventricular Chamber), By Product Type (Conventional, MRI Compatible), By Application (Arrythmias, Congestive Heart Failure, Others), By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE Pacemaker Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in UAE Pacemaker Market.

Contact

Mr. Ken Mathews

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602 

Email: [email protected]

Website: https://www.techsciresearch.com